Share of branded drug costs in Medicare Part D gap in the U.S. 2016-2020

This statistic displays the projected distribution of cost-sharing for brand name drugs in the Medicare Part D coverage gap in the United States from 2016 to 2020. In 2016, five percent of the cost of brand name drugs is expected to be paid by CMS. Provisions of the Affordable Care Act mandate the gradual closure of the Medicare Part D coverage gap through pharmaceutical manufacturer discounts and CMS subsidies.

本统计数据展现了美国2016年至2020年间，针对医疗保险D部分（Medicare Part D）覆盖缺口内品牌药品成本分摊的预测分布。2016年，预计美国医疗保险服务中心（CMS）将承担品牌药品成本的5%。根据《平价医疗法案》的规定，通过制药企业的折扣和医疗保险服务中心的补贴，逐步关闭医疗保险D部分的覆盖缺口被强制执行。